English
简体中文
Total: £ 56.28
Published Date: 2025-09-15 | Pages: 79 | Tables: 79 | Medical Care
The global market for Post Herpetic Neuralgia Therapies was valued at US$ 1713 million in the year 2024 and is projected to reach a revised size of US$ 2234 million by 2031, growing at a CAGR of 3.9% during the forecast period.
Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Post Herpetic Neuralgia Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Post Herpetic Neuralgia Therapies.
The Post Herpetic Neuralgia Therapies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Post Herpetic Neuralgia Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Post Herpetic Neuralgia Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Endo Pharmaceuticals
Depomed
Acorda Therapeutics
Pfizer
Mylan
Daiichi Sankyo
Teikoku Pharma
Segment by Type
Drugs
Patches
Steroid Injectable
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Post Herpetic Neuralgia Therapies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Post Herpetic Neuralgia Therapies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drugs
1.2.3 Patches
1.2.4 Steroid Injectable
1.3 Market by Application
1.3.1 Global Post Herpetic Neuralgia Therapies Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Post Herpetic Neuralgia Therapies Market Perspective (2020-2031)
2.2 Global Post Herpetic Neuralgia Therapies Growth Trends by Region
2.2.1 Global Post Herpetic Neuralgia Therapies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Post Herpetic Neuralgia Therapies Historic Market Size by Region (2020-2025)
2.2.3 Post Herpetic Neuralgia Therapies Forecasted Market Size by Region (2026-2031)
2.3 Post Herpetic Neuralgia Therapies Market Dynamics
2.3.1 Post Herpetic Neuralgia Therapies Industry Trends
2.3.2 Post Herpetic Neuralgia Therapies Market Drivers
2.3.3 Post Herpetic Neuralgia Therapies Market Challenges
2.3.4 Post Herpetic Neuralgia Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Post Herpetic Neuralgia Therapies Players by Revenue
3.1.1 Global Top Post Herpetic Neuralgia Therapies Players by Revenue (2020-2025)
3.1.2 Global Post Herpetic Neuralgia Therapies Revenue Market Share by Players (2020-2025)
3.2 Global Post Herpetic Neuralgia Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Post Herpetic Neuralgia Therapies Revenue
3.4 Global Post Herpetic Neuralgia Therapies Market Concentration Ratio
3.4.1 Global Post Herpetic Neuralgia Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Post Herpetic Neuralgia Therapies Revenue in 2024
3.5 Global Key Players of Post Herpetic Neuralgia Therapies Head office and Area Served
3.6 Global Key Players of Post Herpetic Neuralgia Therapies, Product and Application
3.7 Global Key Players of Post Herpetic Neuralgia Therapies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Post Herpetic Neuralgia Therapies Breakdown Data by Type
4.1 Global Post Herpetic Neuralgia Therapies Historic Market Size by Type (2020-2025)
4.2 Global Post Herpetic Neuralgia Therapies Forecasted Market Size by Type (2026-2031)
5 Post Herpetic Neuralgia Therapies Breakdown Data by Application
5.1 Global Post Herpetic Neuralgia Therapies Historic Market Size by Application (2020-2025)
5.2 Global Post Herpetic Neuralgia Therapies Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Post Herpetic Neuralgia Therapies Market Size (2020-2031)
6.2 North America Post Herpetic Neuralgia Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Post Herpetic Neuralgia Therapies Market Size by Country (2020-2025)
6.4 North America Post Herpetic Neuralgia Therapies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Post Herpetic Neuralgia Therapies Market Size (2020-2031)
7.2 Europe Post Herpetic Neuralgia Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Post Herpetic Neuralgia Therapies Market Size by Country (2020-2025)
7.4 Europe Post Herpetic Neuralgia Therapies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Post Herpetic Neuralgia Therapies Market Size (2020-2031)
8.2 Asia-Pacific Post Herpetic Neuralgia Therapies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Post Herpetic Neuralgia Therapies Market Size by Region (2020-2025)
8.4 Asia-Pacific Post Herpetic Neuralgia Therapies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Post Herpetic Neuralgia Therapies Market Size (2020-2031)
9.2 Latin America Post Herpetic Neuralgia Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Post Herpetic Neuralgia Therapies Market Size by Country (2020-2025)
9.4 Latin America Post Herpetic Neuralgia Therapies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Post Herpetic Neuralgia Therapies Market Size (2020-2031)
10.2 Middle East & Africa Post Herpetic Neuralgia Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Country (2020-2025)
10.4 Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Endo Pharmaceuticals
11.1.1 Endo Pharmaceuticals Company Details
11.1.2 Endo Pharmaceuticals Business Overview
11.1.3 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Introduction
11.1.4 Endo Pharmaceuticals Revenue in Post Herpetic Neuralgia Therapies Business (2020-2025)
11.1.5 Endo Pharmaceuticals Recent Development
11.2 Depomed
11.2.1 Depomed Company Details
11.2.2 Depomed Business Overview
11.2.3 Depomed Post Herpetic Neuralgia Therapies Introduction
11.2.4 Depomed Revenue in Post Herpetic Neuralgia Therapies Business (2020-2025)
11.2.5 Depomed Recent Development
11.3 Acorda Therapeutics
11.3.1 Acorda Therapeutics Company Details
11.3.2 Acorda Therapeutics Business Overview
11.3.3 Acorda Therapeutics Post Herpetic Neuralgia Therapies Introduction
11.3.4 Acorda Therapeutics Revenue in Post Herpetic Neuralgia Therapies Business (2020-2025)
11.3.5 Acorda Therapeutics Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Post Herpetic Neuralgia Therapies Introduction
11.4.4 Pfizer Revenue in Post Herpetic Neuralgia Therapies Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Mylan Business Overview
11.5.3 Mylan Post Herpetic Neuralgia Therapies Introduction
11.5.4 Mylan Revenue in Post Herpetic Neuralgia Therapies Business (2020-2025)
11.5.5 Mylan Recent Development
11.6 Daiichi Sankyo
11.6.1 Daiichi Sankyo Company Details
11.6.2 Daiichi Sankyo Business Overview
11.6.3 Daiichi Sankyo Post Herpetic Neuralgia Therapies Introduction
11.6.4 Daiichi Sankyo Revenue in Post Herpetic Neuralgia Therapies Business (2020-2025)
11.6.5 Daiichi Sankyo Recent Development
11.7 Teikoku Pharma
11.7.1 Teikoku Pharma Company Details
11.7.2 Teikoku Pharma Business Overview
11.7.3 Teikoku Pharma Post Herpetic Neuralgia Therapies Introduction
11.7.4 Teikoku Pharma Revenue in Post Herpetic Neuralgia Therapies Business (2020-2025)
11.7.5 Teikoku Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Post Herpetic Neuralgia Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Drugs
Table 3. Key Players of Patches
Table 4. Key Players of Steroid Injectable
Table 5. Global Post Herpetic Neuralgia Therapies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Post Herpetic Neuralgia Therapies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Post Herpetic Neuralgia Therapies Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Post Herpetic Neuralgia Therapies Market Share by Region (2020-2025)
Table 9. Global Post Herpetic Neuralgia Therapies Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Post Herpetic Neuralgia Therapies Market Share by Region (2026-2031)
Table 11. Post Herpetic Neuralgia Therapies Market Trends
Table 12. Post Herpetic Neuralgia Therapies Market Drivers
Table 13. Post Herpetic Neuralgia Therapies Market Challenges
Table 14. Post Herpetic Neuralgia Therapies Market Restraints
Table 15. Global Post Herpetic Neuralgia Therapies Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Post Herpetic Neuralgia Therapies Market Share by Players (2020-2025)
Table 17. Global Top Post Herpetic Neuralgia Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post Herpetic Neuralgia Therapies as of 2024)
Table 18. Ranking of Global Top Post Herpetic Neuralgia Therapies Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Post Herpetic Neuralgia Therapies Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Post Herpetic Neuralgia Therapies, Headquarters and Area Served
Table 21. Global Key Players of Post Herpetic Neuralgia Therapies, Product and Application
Table 22. Global Key Players of Post Herpetic Neuralgia Therapies, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Post Herpetic Neuralgia Therapies Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Type (2020-2025)
Table 26. Global Post Herpetic Neuralgia Therapies Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Type (2026-2031)
Table 28. Global Post Herpetic Neuralgia Therapies Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Application (2020-2025)
Table 30. Global Post Herpetic Neuralgia Therapies Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Application (2026-2031)
Table 32. North America Post Herpetic Neuralgia Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Post Herpetic Neuralgia Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Post Herpetic Neuralgia Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Post Herpetic Neuralgia Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Post Herpetic Neuralgia Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Post Herpetic Neuralgia Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Post Herpetic Neuralgia Therapies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Post Herpetic Neuralgia Therapies Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Post Herpetic Neuralgia Therapies Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Post Herpetic Neuralgia Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Post Herpetic Neuralgia Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Post Herpetic Neuralgia Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Country (2026-2031) & (US$ Million)
Table 47. Endo Pharmaceuticals Company Details
Table 48. Endo Pharmaceuticals Business Overview
Table 49. Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Product
Table 50. Endo Pharmaceuticals Revenue in Post Herpetic Neuralgia Therapies Business (2020-2025) & (US$ Million)
Table 51. Endo Pharmaceuticals Recent Development
Table 52. Depomed Company Details
Table 53. Depomed Business Overview
Table 54. Depomed Post Herpetic Neuralgia Therapies Product
Table 55. Depomed Revenue in Post Herpetic Neuralgia Therapies Business (2020-2025) & (US$ Million)
Table 56. Depomed Recent Development
Table 57. Acorda Therapeutics Company Details
Table 58. Acorda Therapeutics Business Overview
Table 59. Acorda Therapeutics Post Herpetic Neuralgia Therapies Product
Table 60. Acorda Therapeutics Revenue in Post Herpetic Neuralgia Therapies Business (2020-2025) & (US$ Million)
Table 61. Acorda Therapeutics Recent Development
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Post Herpetic Neuralgia Therapies Product
Table 65. Pfizer Revenue in Post Herpetic Neuralgia Therapies Business (2020-2025) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Mylan Company Details
Table 68. Mylan Business Overview
Table 69. Mylan Post Herpetic Neuralgia Therapies Product
Table 70. Mylan Revenue in Post Herpetic Neuralgia Therapies Business (2020-2025) & (US$ Million)
Table 71. Mylan Recent Development
Table 72. Daiichi Sankyo Company Details
Table 73. Daiichi Sankyo Business Overview
Table 74. Daiichi Sankyo Post Herpetic Neuralgia Therapies Product
Table 75. Daiichi Sankyo Revenue in Post Herpetic Neuralgia Therapies Business (2020-2025) & (US$ Million)
Table 76. Daiichi Sankyo Recent Development
Table 77. Teikoku Pharma Company Details
Table 78. Teikoku Pharma Business Overview
Table 79. Teikoku Pharma Post Herpetic Neuralgia Therapies Product
Table 80. Teikoku Pharma Revenue in Post Herpetic Neuralgia Therapies Business (2020-2025) & (US$ Million)
Table 81. Teikoku Pharma Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
Table 85. Authors List of This Report
List of Figures
Figure 1. Post Herpetic Neuralgia Therapies Picture
Figure 2. Global Post Herpetic Neuralgia Therapies Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Post Herpetic Neuralgia Therapies Market Share by Type: 2024 VS 2031
Figure 4. Drugs Features
Figure 5. Patches Features
Figure 6. Steroid Injectable Features
Figure 7. Global Post Herpetic Neuralgia Therapies Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Post Herpetic Neuralgia Therapies Market Share by Application: 2024 VS 2031
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Post Herpetic Neuralgia Therapies Report Years Considered
Figure 13. Global Post Herpetic Neuralgia Therapies Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Post Herpetic Neuralgia Therapies Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Post Herpetic Neuralgia Therapies Market Share by Region: 2024 VS 2031
Figure 16. Global Post Herpetic Neuralgia Therapies Market Share by Players in 2024
Figure 17. Global Top Post Herpetic Neuralgia Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post Herpetic Neuralgia Therapies as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Post Herpetic Neuralgia Therapies Revenue in 2024
Figure 19. North America Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Post Herpetic Neuralgia Therapies Market Share by Country (2020-2031)
Figure 21. United States Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Post Herpetic Neuralgia Therapies Market Share by Country (2020-2031)
Figure 25. Germany Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Post Herpetic Neuralgia Therapies Market Share by Region (2020-2031)
Figure 33. China Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Post Herpetic Neuralgia Therapies Market Share by Country (2020-2031)
Figure 41. Mexico Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Post Herpetic Neuralgia Therapies Market Share by Country (2020-2031)
Figure 45. Turkey Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Post Herpetic Neuralgia Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Endo Pharmaceuticals Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2020-2025)
Figure 49. Depomed Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2020-2025)
Figure 50. Acorda Therapeutics Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2020-2025)
Figure 52. Mylan Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2020-2025)
Figure 53. Daiichi Sankyo Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2020-2025)
Figure 54. Teikoku Pharma Revenue Growth Rate in Post Herpetic Neuralgia Therapies Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
